chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: MMR
Symptoms: Immunoglobulin therapy, Measles
Clinical narrative: Information has been received from a nurse concerning a male who on 25-SEP-2007 was vaccinated with one dose of MMR II (HSA) (lot# 652483/0148F). The nurse reported that the "last week", on approximately 20-APR-2009 the patient was diagnosed with measles. The patient was treated with immune globulin. The patient sought medical attention by an office visit. No further information is available.
Age: 33.0
Sex: M
Vaccine: MMR
Symptoms: Measles
Clinical narrative: Information has been received from a website concerning a 33 year old male who was vaccinated with a dose of MMR II as a child. On an unspecified date the patient experienced measles. The outcome was unknown. Additional information has been requested.
Sex: M
Vaccine: MMR
Symptoms: Autism spectrum disorder
Clinical narrative: Information has been received from a consumer concerning a male who was vaccinated with MMR II. Three weeks after receiving MMR II the patient was diagnosed with PPD. It was unknown if the patient sought medical attention. At the time of the report the outcome of the patient was unknown. No further information is available.
Age: 30.0
Sex: F
Vaccine: MMR
Symptoms: Blood test, Facial palsy
Clinical narrative: Information has been received from a 30 year old female patient with no pertinent medical history and no known drug allergies/drug reactions who on 07-APR-2009 was vaccinated with a dose of MMR II (Lot # 662815/1362X).  There was no concomitant medication.  It was reported that on 09-APR-2009 the patient experienced Bells palsy.  The patient sought unspecified medical attention.  An "unspecified blood work" was performed (results not provided).  It was reported that the patient had not recovered at the time of the report.  This is one of several cases from the same source.  No further information is available.
Age: 4.0
Sex: F
Vaccine: MMR
Symptoms: Pyrexia, Rash
Clinical narrative: Information has been received from a consumer concerning her 4.5 year old daughter with no medical history and drug allergies who at 15 months of age was vaccinated with the first dose of MMR II a couple days later experienced high fever and a rash.  On an unspecified date the patient was recovered.  Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: DTP, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Information has been received from an office manager concerning a 5 year old boy who was vaccinated with a dose of MMR II and VARIVAX (Merck) in one arm on an unspecified date. Then the patient was vaccinated with a dose of IPOL and diphtheria toxoid (+) pertussis vaccine (unspecified) (+) tetanus toxoid in the other arm on the same day. After receiving MMR II and VARIVAX (Merck), the patient's arm was swollen, red and hot from his elbow all the way up to his shoulder. There was no adverse reaction specified on the other arm. The patient was given BENADRYL and CORTIZONE. The reporter believed the patient had recovered since no information was heard from the patient's parents. The patient sought unspecified medical attention. Follow up information was received from an office manager via a letter concerning the patient experienced swelling and redness at the site. Subsequently, the symptoms resolved. The patients name was not available. This is one of several reports received from the same source. Additional information is not expected.
Age: 5.0
Sex: F
Vaccine: DTP, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Information has been received from an office manager concerning one 5 year old girl and one 5 year old boy who were vaccinated with a dose of MMR II and VARIVAX (Merck) in one arm on an unspecified date.  Then the patients were vaccinated with a dose of IPOL and DTAP in the other arm on the same day.  After receiving MMR II and VARIVAX (Merck), the patient's arms were swollen, red and hot from their elbow all the way up to their shoulders.  There was no adverse reaction specified on the other arm.  The patients were given BENADRYL and CORTIZONE.  The reporter believed the patients had recovered since no information was heard from the patient's parents.  The patient sought unspecified medical attention.  This is one of several reports received from the same source.  Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Antibody test negative
Clinical narrative: Information has been received from a pharmacist concerning a patient who had negative titers after receiving a dose of MMR II. The pharmacist did not know if the patient was given 1 or 2 doses of vaccine in the past. The pharmacist also did not know if the patient was negative to measles, mumps or rubella. No further information is available. Correspondence attempts were unsuccessful.
Age: 18.0
Sex: M
Vaccine: MMR
Symptoms: Mumps antibody test negative, Unevaluable event
Clinical narrative: Information has been received from a Registered Nurse concerning an 18 year old male patient who at age 1 year was vaccinated with MMR II (lot # not reported) and 5 years of age he received a booster of MMR II. He will be traveling abroad and recent titers were for measles and rubella but a negative titer of mumps. No symptoms presented. The patient sought attention was at office. Additional information has been requested.
Age: 5.0
Sex: U
Vaccine: MMR
Symptoms: Inappropriate schedule of drug administration, Mumps antibody test
Clinical narrative: Information has been received from a medical assistant concerning a patient who on 03-JAN-1992 was vaccinated with a first dose of MMR II prior to 12 months old. The patient received the second dose of MMR II on 29-MAY-1996. The patient was going to college and had a negative titer for the mumps. The mumps titer was 0.82. The patient sought medical attention through a phone call. Additional information has been requested.
Sex: M
Vaccine: MMR
Symptoms: Antibody test negative, Measles antibody negative
Clinical narrative: Information has been received from a registered nurse concerning a male who in 1961, was vaccinated with MMR II (lot number, route and site of administration not reported). It was reported that the patient was vaccinated as a child and at the time of reporting the patient had low titers. Additional information has been requested.
Age: 42.0
Sex: F
Vaccine: MMR
Symptoms: Antibody test negative, Rubella antibody negative
Clinical narrative: Information has been received from a registered nurse concerning a 42 year old female patient with no pertinent medical history and no drug reactions or allergies who in 1987 was vaccinated with a dose of MMR II (Lot # not reported). Concomitant therapy included NEXIUM, hydrochlorothiazide (manufacturer unknown) and naproxen. In 2009 rubella titer was performed and was negative. No adverse effects were reported. Follow-up information received from the registered nurse reported that the patient "was not given" a dose of MMR II. The nurse reported that she was asking "if a patient had received 2 doses of MMR II should they receive more dose if the rubella titer was negative". No further information was provided at this time. Additional information is not expected.
Age: 1.48
Sex: M
Vaccine: MMR
Symptoms: Mumps, Parotitis, Pyrexia
Clinical narrative: Information has been received from a physician concerning a 14 year old male who on 04-NOV-1994 was vaccinated with the first dose of MMR II (route, site, dose and lot number not reported). On 04-JUN-1996, the patient was vaccinated with a second dose of MMR II (route, site, dose and lot number not reported). On 13-NOV-2009, the patient experienced mumps (thought the date diagnosed was reported as 29-NOV-2009). The patient was febrile (101.5F) and had parotitis. The outcome for mumps was not reported. This is one of several reports from the same source. No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Blood immunoglobulin G, Blood immunoglobulin M, Facial pain, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning a 10 year old male who on 26-OCT-2000 was vaccinated with a first dose of MMR II (HSA) (route, site, dose and lot number not reported). On 10-AUG-2003, the patient was vaccinated with a second dose of MMR II (HSA) (route, site, dose and lot number not reported). On 02-JAN-2010, the patient experienced mumps (thought the date diagnosed was reported as 19-NOV-2009). The patient was afebrile and did not have parotitis. The outcome for mumps was not reported. Follow up was received from a physician. It was reported that the 10 year old (also reported as 9 year old) patient experienced mumps on 19-JAN-2010. The diagnosis date was on 19-JAN-2010. On the same date, the patient had several tests performed: IgM <1:10, IgG was 1.96 and serum amylase was 36. The patient had left facial pain, and left parotitis. It was unknown if the patient had orchitis, there were no other symptoms. It was unknown if the patient had exposure to other with mumps (sib, classmate) or if there was other case in same household. There was no third dose of MMR II given. At the time of reporting, the patient's outcome was unknown. Additional information is not expected.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Blood immunoglobulin G, Blood immunoglobulin M, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning a 14 year old male who on 11-NOV-1996 was vaccinated with a first dose of MMR II (route, site, dose and lot number not reported). On 25-JAN-2000, the patient was vaccinated with a second dose of MMR II (route, site, dose and lot number not reported). On 12-NOV-2009, the patient experienced mumps (the date diagnosed was reported as 03-JAN-2010). The patient was afebrile and did have parotitis. The outcome for mumps was not reported. Follow up was received from a physician. It was reported that the 14 year old patient experienced mumps on 12-NOV-2009. The diagnosis date was on 12-NOV-2009. On the same date, the patient had several tests performed: IgM was <1:10, IgG was 3.36 and serum amylase was 95. The patient had right parotitis and was afebrile. On 27-NOV-2009, the patient had several tests performed: IgM was 1:20:00 and serum amylase was 9.04. At the time of reporting, the patient's outcome was unknown. Additional information is not expected.
Age: 4.0
Sex: F
Vaccine: MMR
Symptoms: Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning a 10 year old female who on 21-JUN-2001 was vaccinated with a first dose of MMR II (route, site, dose and lot number not reported). On 30-JUL-2003, the patient was vaccinated with a second dose of MMR II (route, site, dose and lot number not reported). On 20-NOV-2009, the patient experienced mumps (the date diagnosed was reported as 03-JAN-2010). The patient was afebrile and did not have parotitis. The outcome for mumps was not reported. Follow-up information was received from the physician concerning the 10 year old female patient (also reported as 8 years old). It was reported that the mumps onset date was 14-JAN-2010 (previously reported as 20-NOV-2010)/. The patient was diagnosed with 17-JAN-2010 (previously reported as 03-JAN-2010). The patient had right parotitis. At the time of reporting the patient's final outcome remained unknown. This is one of several reports from the same source. No further information is available.
Age: 4.0
Sex: F
Vaccine: MMR
Symptoms: Blood immunoglobulin G, Blood immunoglobulin M, Mumps, Oropharyngeal pain, Parotitis
Clinical narrative: Information has been received from a physician concerning a 15 year old female who on 20-AUG-1995 was vaccinated with a first dose of MMR II (route, site, dose and lot number not reported). On 24-NOV-1998, the patient was vaccinated with a second dose of MMR II (route, site, dose and lot number not reported). On 22-NOV-2009, the patient experienced mumps (thought the date diagnosed was reported as 01-DEC-2009). The patient was afebrile and did not have parotitis. The outcome for mumps was not reported. Follow-up information was received from a physician who reported that the patient experienced mumps on 15-NOV-2009 (previously reported as 22-NOV-2009) and was diagnosed on 18-NOV-2009 (previously reported as 01-DEC-2009). It was reported that the patient had left parotitis and as other symptoms sore throat. On 18-NOV-2009, the following labs were taken: serum immunoglobulin M test which showed < 1:10, serum immunoglobulin G test which showed 2.27 and serum amylase test which 352. This is one of several reports from the same source. No further information is available.
Age: 10.0
Sex: M
Vaccine: MMR
Symptoms: Body temperature increased, Mumps
Clinical narrative: Information has been received from a physician concerning a 10 year old (also reported as 9 year old) male who on an unspecified date was vaccinated with a dose of MMR II (route, site, dose and lot number not reported). On 30-DEC-2009, the patient experienced mumps (date diagnosed was reported as 01-JAN-2010). The patient had a temp of 102.7 degrees F. The outcome for mumps was not reported. No further information is available.
Age: 4.0
Sex: F
Vaccine: MMR
Symptoms: Blood amylase increased, Body temperature increased, Cough, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning a 16 year old female who on 25-MAR-1996 was vaccinated with a first dose of MMR II (route, site, dose and lot number not reported respectively). On 18-JAN-1998, the patient was vaccinated with a second dose of MMR II (route, site, dose and lot number not reported). On 19-NOV-2009 the patient experienced mumps. Lab results for 19-NOV-2009: IgM was<1:10, IgG was 9.13 and Serum Amylase was 30. The patient was afebrile. The outcome for mumps was not reported. Follow up information has been received from the physician concerning a 16 year old (also reported as 14 year old) female patient who on 25-MAR-1996 was vaccinated with a first dose of MMR II (route, site, dose and lot number not reported respectively). On 18-JAN-1998, the patient was vaccinated with a second dose of MMR II (route, site, dose and lot number not reported). On 10-NOV-2009 the patient experienced mumps (also reported as 19-NOV-2009). The patient was diagnosed with mumps on 11-JAN-2010. Labs results for 11-JAN-2009: IgM was<1:10, IgG was 5.87 and Serum Amylase was 550. The patient had left parotitis and experienced cough. The final outcome for mumps was not reported. This is one of several reports from the same source. No further information is available.
Age: 1.06
Sex: F
Vaccine: MMR
Symptoms: Abdominal pain upper, Mumps, Parotitis, Pyrexia
Clinical narrative: Information has been received from a physician concerning a 10 year old female who on 19-SEP-2000 was vaccinated with a dose of MMR II (route, site, dose and lot number not reported).  On 22-NOV-2009 the patient experienced onset of mumps, diagnosed on 06-DEC-2009.  On 22-NOV-2009 the patient experienced onset of mumps, diagnosed on 06-DEC-2009.  The patient was febrile and had left and right parotitis.  The outcome for mumps was not reported.  Follow up information has been received from a physician concerning a 10 year old (also reported as 19 year) female who on 13-DEC-2009 experienced mumps, diagnosed on 14-DEC-2009.  The patient was febrile, had left parotitis and stomachache.  On 14-DEC-2009 laboratories test revealed: serum immunoglobulin M test: < 1:10, serum immunoglobulin G test : 10.07 and serum amylase test: 73.  The outcome for mumps was not reported.  No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Blood amylase, Blood immunoglobulin G, Blood immunoglobulin M, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning a 15 year old male who on 23-MAR-1995 was vaccinated with a first dose of MMR II (route, site, dose and lot number not reported). On 27-FEB-1998, the patient was vaccinated with a second dose of MMR II (route, site, dose and lot number not reported). On 20-NOV-2009 the first set of blood tests for IgM was < 1:10, IgG was 4.04 and serum amylase was 86. On 14-DEC-2009 the patient's 2nd blood test revealed IgM 1:10:00 and IgG was 12.76. On 18-NOV-2009 the patient experienced mumps (the date diagnosed was reported as 20-NOV-2009). The patient was afebrile and had parotitis. The outcome for mumps was not reported. This is one of several reports from the same source. No further information is available.
Age: 1.02
Sex: F
Vaccine: MMR
Symptoms: Pyrexia, Rash
Clinical narrative: Information has been received from a mother and a registered nurse concerning a 12 month old female patient with no known drug allergies and no pertinent medical history who on 21-SEP-2004 was vaccinated with the initial dose of MMR II.  Concomitant therapy included pneumococcal vaccine (unspecified).  According to the mother, the patient developed full blown rubella.  She added that the patient "started developing the rashes 3 to 4 days after administration of the MMR II and she also developed high fever".  It was also reported that the mother and her husband brought the patient to the physician's office right away but the physician did not even bother to look at the patient that time.  The mother stated that the patient was brought to the clinic 3 times.  In the middle of October, 2004 the patient recovered.  According to the registered nurse the rash that the mother of the child described as "full blown rubella" was never confirmed by a physician.  She indicated that the medical records stated that the child was exposed to a rash.  Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Abdominal discomfort, Blood immunoglobulin G, Blood immunoglobulin M, Headache, Local swelling
Clinical narrative: Information has been received from a physician concerning a 15 year old male who on 26-FEB-1998 was vaccinated with a first dose of MMR II (route, site, dose and lot number not reported). On 27-MAR-1999, the patient was vaccinated with a second dose of MMR II (route, site, dose and lot number not reported). On 10-NOV-2009 the patient experienced mumps (the date diagnosed was reported as 14-DEC-2009). Lab results for 14-DEC-2009: IgM was <1:10, IgG was 9.38 and Serum Amylase was 327. The patient was afebrile. He presented swollen neck for a day. The outcome for mumps was not reported. Follow-up information was received from a physician concerning the 15 year old patient (also reported as 14 years old). It was reported that the patient was diagnosed with mumps on 16-NOV-2010 (previously reported as 14-DEC-2009). The patient had stomach symptoms, headache and was afebrile. On 16-Nov-2009 the following laboratory test results were obtained: serum immunoglobulin G test 8.99; serum immunoglobulin M test which was negative and serum amylase test 112. At the time of reporting the patient's final outcome remained unknown. This is one of several reports from the same source. No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Mumps
Clinical narrative: Information has been received from a physician concerning a 15 year old male who on 26-FEB-1998 was vaccinated with a first dose of MMR II (route, site, dose and lot number not reported). On 27-MAR-1999, the patient was vaccinated with a second dose of MMR II (route, site, dose and lot number not reported). On 10-NOV-2009 the patient experienced mumps (the date diagnosed was reported as 14-DEC-2009). Lab results for 14-DEC-2009: IgM was <1:10, IgG was 9.38 and Serum Amylase was 327. The patient was afebrile. He presented swollen neck for a day. The outcome for mumps was not reported. Follow-up information was received from a physician concerning the 15 year old patient (also reported as 14 years old). It was reported that the patient was diagnosed with mumps on 16-NOV-2010 (previously reported as 14-DEC-2009). The patient had stomach symptoms, headache and was afebrile. On 16-Nov-2009 the following laboratory test results were obtained: serum immunoglobulin G test 8.99; serum immunoglobulin M test which was negative and serum amylase test 112. At the time of reporting the patient's final outcome remained unknown. This is one of several reports from the same source. No further information is available.
Age: 1.04
Sex: M
Vaccine: FLU3, MMR, VARCEL
Symptoms: Immediate post-injection reaction, Injection site erythema, Injection site induration, Injection site urticaria
Clinical narrative: Information has been received from a registered nurse concerning a 12 month old male patient with no known drug allergies and no pertinent medical history who on 09-SEP-2009 was vaccinated with MMR II (Lot #664607/0609Y) in the right thigh. On the same day the patient was vaccinated with VARIVAX (MSD) (WAES #0910USA01603) and influenza virus vaccine (unspecified) which according to the reporter were administered during the same visit. It was also reported that  the patient developed a wheal at injection site immediately after administration of MMR II. The nurse stated that erythema and induration were developed after ten minutes. The patient was treated with BENADRYL. The patient recovered on the same day. No lab diagnostic tests were performed. Follow up information has been received from the registered nurse who indicated that on 09-SEP-2009 the patient was vaccinated subcutaneously with his first dose of MMR II (Lot #664607/0609Y) in the right thigh. Concomitant vaccination included the first dose of VARIVAX (MSD) (Lot#664905/0865Y) (WAES # 0910USA01603) administered subcutaneously in the left thigh and the first dose of FLUZONE administered intramuscularly in the left thigh. According to the nurse, immediately post injection of MMR II (Lot #664607/0609Y) there was a wheal, erythema and induration around the injection site. No other symptoms were reported. The patient recovered 30 minutes later. This is one of several reports received from the same source. No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Blood amylase increased, Mumps, Parotitis
Clinical narrative: Information has been received from a physician concerning an 18 year old male who on 12-JUN-1992 was vaccinated with a first dose of MMR II (route, site, dose and lot number not reported).  On 7-JUN-1996, the patient was vaccinated with a second dose of MMR II (route, site, dose and lot number not reported).  On 11-NOV-2009 the patient experienced mumps.  Lab results for 11-NOV-2009: IgM was negative, IgG was 3.3 and Serum Amylase was 221.  The patient was afebrile.  The outcome for mumps was not reported.  Follow up information has been received concerning an 18 year old male patient who on 12-JUN-1992 and 07-JUN-1996 was vaccinated with the first and second doses of MMR II (route, site, dose and lot number not reported).  On 16-NOV-2009, the patient experienced mumps (thought the date diagnosed was reported as 17-NOV-2009). The patient was afebrile and had L parotitis.  On 17-NOV-2009 a first blood work was performed with negative result and on an unspecified date an IgG and a serum amylase test were performed and the results were 5.88 and 97, respectively.  The outcome for mumps was not reported.  This is one of several reports from the same source.  No further information is available.
Age: 5.0
Sex: M
Vaccine: MMR
Symptoms: Antibody test negative, Expired drug administered, Measles antibody negative, Mumps antibody test positive, Rubella antibody positive
Clinical narrative: Information has been received form a Licensed Practical Nurse (L.P.N.) concerning a patient who on 28-MAY-2009 was vaccinated with the second dose of MMR II but it was expired. The product expired on 25-APR-2009. No adverse reactions were reported. The patient was vaccinated with the first dose vaccine on 22-JUL-2005. Follow up information was received from the Registered Nurse (R.N.) (previous reported as Licensed Practical Nurse) on 29-JUN-2009 via telephone. The nurse mentioned a titer for the patient was done on 23-JUN-2009 and the results for measles was 0.52 which indicated no significant level of antibody. The patient had a significant level of antibody for mumps and rubella. No further information is available. Follow up information was received form the Registered Nurse (R.N.) concerning the 5 year old male patient with no known drug allergies who on 28-MAY-2009 at 4:30 pm was vaccinated intramuscularly in the arm with the second dose of MMR II (lot # 07464). There were no illnesses at the time of vaccination. The patient was vaccinated with the first dose of MMR II(#649229/0149R) on 22-JUL-2005. There was no illness at the time of vaccination. No adverse reactions were reported after the out date immunization was given. Laboratory tests were performed on 23-JUN-2009. Titer showed rubeola IgM was 0.52 at 28 days after immunization. It was negative for immunity. Mumps titer was positive. Rubella IgG was reactive. The patient would be reimmunization on 10-JUL-2009. No further information is available.
Age: 1.02
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Immediate post-injection reaction, Injection site urticaria, Rash
Clinical narrative: Information has been received from a registered nurse concerning a 12 month old female patient with no drug reactions/allergies or pertinent medical history, who on 06-OCT-2009 was vaccinated with a dose of MMR II (Lot number 664801/0764Y). Concomitant therapy included VARIVAX (Lot number 665103/1001Y). The registered nurse reported that the patient developed a 1 inch wheal at the injection site on the right thigh immediately after administration of MMR II. Patient was also given VARIVAX in the left thigh during the same visit. The patient was treated with BENADRYL. Subsequently, the wheal went away after 15 to 20 minutes. The patient sought medical attention during the office visit. This is one of several reports received from the same source. Follow up information has been received from the physician concerning a female patient with no drug reactions/allergies or pertinent medical history who on 06-OCT-2009 was vaccinated SQ/RT with a dose of MMR II (Lot number 664801/0764Y). There was no illness at the time of vaccination. "Minutes" after vaccination, the patient developed a dime sized urticaria wheal adjacent to injection site. No respiratory symptoms. The patient was given 2.5 ml of BENADRYL. Subsequently 10 minutes later the rash resolved. No further information is available.
Age: 48.0
Sex: M
Vaccine: MMR
Symptoms: No therapeutic response, Rubella antibody negative
Clinical narrative: Information has been received a healthcare worker concerning a 48 year old male patient who on an unspecified date was vaccinated with a dose of MMR II as an adult. Subsequently, on an unknown date the patient experienced negative rubella titer. The patient sought medical attention via office visit. At the time of the report, the patient's status was unknown. Follow-up information has been received from a physician. It was reported that the patient did not have an adverse reaction to a dose of MMR II. It was also reported that the patient was afraid he would get an adverse reaction to MMR II because he received one dose in 1979 and the listing of serious events of the vaccine state that he is at higher risk for serious events getting a second dose. Follow-up information has been received from the healthcare worker. It was reported that the patient never completed the MMR II series and there was no adverse effect involved. Additional information is not expected.
Age: 23.0
Sex: F
Vaccine: MMR
Symptoms: Measles antibody negative, No therapeutic response
Clinical narrative: Information has been received from a medical student concerning a female with no medical history or allergy who in the past was vaccinated with MMR II. There was no concomitant medication. The patient had a low measles titer. The medical student was not sure if the patient had received one of two doses of MMR II. The lab studies were performed with titers. The patient sought unspecified medical attention. Follow-up information has been received from a physician who reported the patient had received MMR II and measles titers showed ineffective titers. They did not administer the vaccine, it was done by prior pediatrician. The patient had recovered. Follow-up information has been received from a physician of the pediatric group who reported that the patient had not been seen since 2004. No further information is available.
Age: 1.1
Sex: M
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Information has been received from a licensed practical nurse concerning a 13 month old male who on 12-AUG-2009 was vaccinated with the first dose of VARIVAX (Merck) (lot # 664021/0502Y) 0.5 mL subcutaneously.  On 13-AUG-2009, the patient experienced large area of redness and swelling at the injection site of the left upper arm.  The patient's mother called the office and was recommended to give the patient TYLENOL and apply cool compresses.  The patient had subsequently fully recovered.  No laboratory diagnostic test were performed.  The nurse added that quite a few other patients have had similar injections site reactions over the last couple of months.  This is one of two reports from the same source.  Additional information has been requested.
Sex: M
Vaccine: MMR
Symptoms: Rash
Clinical narrative: Information has been received from a consumer concerning the brother of her daughter's classmate who on an unknown date was vaccinated with MMR II. It was reported that the patient developed a rash from shoulder to elbow after receiving MMR II. The patient's final outcome was not reported. Attempts to verify the existence of identifiable patients have been unsuccessful. This is one of two reports received from the same source. No further information is available.
Age: 42.0
Sex: F
Vaccine: MMR
Symptoms: Measles antibody negative, No therapeutic response
Clinical narrative: Information has been received from a nurse concerning a 42 year old female patient with no pertinent medical history and sulfonamide allergy who on unspecified dates was vaccinated with doses of MMR II (lot number not reported). The nurse stated that the patient did say she got the vaccine as a child. Titer drawn on 31-JUL-2009 showed the patient was not immune. On 07-AUG-2009 the patient was vaccinated with a dose of MMR II (lot number not reported). Titer drawn on 03-OCT-2009 showed that measles was equivocal. Unspecified medical attention was sought. At the time of the report, the outcome of the patient was not reported. The patient had a medical history of Anti-HBs antibody negative after being vaccinated with a 3 doses of hepatitis B virus vaccine rHBsAg (manufacturer unknown, WAES # 0910USA00596). This is one of several reports from the same source. Additional information has been requested.
Sex: M
Vaccine: MMR
Symptoms: Pyrexia, Rash
Clinical narrative: Information has been received from a consumer concerning her son with gelatin allergy who on 17-NOV-2009 was vaccinated with a dose of MMR II (lot # not reported). On 20-NOV-2009 3 days after receiving the vaccine the patient developed a fever and rash. The patient sought unspecified medical attention. On an unspecified date, the patient recovered from fever and rash. No further information is available.
Age: 1.03
Sex: M
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning a 12 year old male patient who on 23-AUG-1997 was vaccinated with the first dose of VARIVAX (Merck) (Lot not reported). On 03-MAY-2009 the patient developed a pustule vesicles and the physician diagnosed it as chicken pox. At the time of reporting on 01-MAY-2009, the patient's chicken pox persisted. Additional information has been requested.
Age: 42.0
Sex: M
Vaccine: MMR
Symptoms: No therapeutic response, Rubella antibody negative
Clinical narrative: Information has been received from a certified medical assistant concerning a 42 year old male with no allergies who was vaccinated with a dose of MMR II. The patient had a negative for the rubella. Office had no this vaccination history for this patient. Rubella titer test was taken from about a week ago on approximately 01-JUN-2009 and the result was negative. The patient was seen for a physical to seek medical attention. Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Allergy test negative, Urticaria
Clinical narrative: Information has been received from a physician assistant concerning a 5 year old male patient who on an unspecified date was vaccinated with the second dose of MMR II (route and lot #unknown) and the second dose of VARIVAX (Merck). The physician assistant reported that the child developed hives 2 to 3 hours after receiving MMR II and VARIVAX (Merck). The child was tested by an allergist for egg, neomycin and gelatin allergies with all negative results. The patient sought unspecified medical attention. At the time of this report the patient's urticaria was resolved. No further information is available.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Lip swelling
Clinical narrative: Information has been received from a physician concerning a 4 year old male patient who on an unknown date was vaccinated with a dose of MMR II. On 29-JAN-2010 the patient developed swollen lips, but the physician did not specify how long after getting the dose of MMR II this happened. The patient's outcome at the time of the report was unknown. It was unknown if the patient sought medical attention. Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Varicella
Clinical narrative: Information has been received from a Registered Nurse (R.N.) concerning a female patient with no pertinent medical history and no known drug allergies/drug reactions, who on 21-APR-2009 was vaccinated with the first 0.5 ml dose of VARIVAX (Merck) subcutaneously.  There was no concomitant therapy reported.  It was reported that "early this week" (approximately 04-MAY-2009) the patient had about 5 "pox" lesions on her body and a red area on her arm, at the injection site.  The patient sought medical attention via phone call.  There were no laboratory diagnostic tests performed.  It was reported that the patient was recovering at the time of the report.  Additional information has been requested.
Sex: M
Vaccine: HIBV, MMR, PPV
Symptoms: Encephalitis, Pyrexia
Clinical narrative: Information has been received from a pharmacist concerning an adult male patient with a history of multiple myeloma and stem cell transplant who on an unspecified date was vaccinated with a dose of MMR II. Secondary suspect vaccination administered on the same day included a dose of PNEUMOVAX. Other concomitant vaccination administered on the same day included a dose of HIB vaccine (manufacturer unknown). Within 24 hours of vaccination the patient developed encephalitis. Subsequently, the patient recovered from developed encephalitis within 24 hours of vaccination. The patient was also febrile. The patient contacted the pharmacist. At the time of the report, the patient recovered on an unknown date. Upon internal review, encephalitis was considered to be an other important medical event. Additional information has been requested.
Sex: U
Vaccine: MMR, TTOX
Symptoms: Asthenia, Pyrexia
Clinical narrative: Information has been received from a physician concerning a patient who in approximately 2008, "less than one year ago", was vaccinated with a dose of MMR II. Concomitant therapy included tetanus toxoid. In approximately 2008, "after receiving the vaccine", the patient developed symptoms. The patient developed fever of 102 degrees F with weakness. The outcome was unknown. It was not specified if the patient sought medical attention or not. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Arthralgia, Rash morbilliform
Clinical narrative: Information has been received from a female health professional concerning herself who in 1998 was vaccinated with a dose of MMR II. The nurse developed joint aching and a mild measles-like rash 1 week after receiving a dose of MMR II in 1998. The symptoms resolved without requiring treatment. The nurse did not want to be contacted regarding this adverse event. No further information is available.
Age: 9.0
Sex: F
Vaccine: VARCEL
Symptoms: Chest pain, Urticaria, Vaccine positive rechallenge, Vomiting
Clinical narrative: Information has been received from a physician concerning a 9 year old female with strabismus who on 21-APR-2009 was vaccinated with the third dose of VARIVAX (Merck) (lot# not reported) IM into the right arm. On 21-APR-2009 the patient developed chest pain, vomiting followed by urticarial rash around face and neck and rare on trunk. The symptoms relieved with MAALOX and BENADRYL. The patient had similar reactions at the age of 7 and a half years after the second dose of VARIVAX (Merck) (lot# not reported), but her parents didn't remember until after the patient was given the third dose mistakenly. Subsequently, on 21-APR-2009, the patient recovered from chest pain, vomiting and urticarial rash around face. The patient sought medical attention by visiting the doctor. Additional information is not expected.
Age: 28.0
Sex: F
Vaccine: MMR
Symptoms: Laboratory test normal, No therapeutic response
Clinical narrative: Information has been received from a pharmacist concerning an about 28 year old female who was vaccinated with the second dose of MMR II (0.5ml, subcutaneous injection, lot# and site of administration not reported) last month.  The patient had a negative titer to one of the components of MMR II (unspecified which component) by the titer taken about a week ago.  Unspecified medical attention was sought by the patient.  The outcome of the patient was unknown.  Additional information has been requested.
Age: 40.0
Sex: M
Vaccine: MMR
Symptoms: Injection site swelling, Local reaction
Clinical narrative: Information has been received from a physician concerning a male patient "in his 40's" with a history of mumps and rubella as a child who on an unspecified date was vaccinated with a dose of MMR II.  Subsequently the patient had a "severe local reaction with swelling at the injection site".  Medical attention was sought, the patient spoke to the physician.  It was unspecified if lab studies were performed.  At the time of the report, the patient had not recovered.  Additional information has been requested.
Age: 7.0
Sex: F
Vaccine: MMR
Symptoms: Hypersensitivity
Clinical narrative: Information has been received from a consumer concerning her 7 year old daughter with "a severe egg allergy" who "a while back" was vaccinated with a dose of MMR II. Subsequently (a while back), the patient had severe reaction. At the time of this report, the patient's outcome was unspecified. It was unknown if the patient has sought medical attention. No further information is available.
Age: 5.0
Sex: M
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Information has been received from a medical assistant concerning a 5 year old male who on 15-APR-2009 was vaccinated subcutaneously with a 0.5mL dose of VARIVAX (Merck) (LOT# 662577/0047Y). On an unspecified date after vaccination the patient experienced injection site redness and swelling. It also reported that unspecified medical attention was sought and the patient was recovered. A lot check has been initiated. A standard lot check investigation was performed. All in-process quality checks for the lot number in question were satisfactory. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. (Complaint ID # 154674). This is one of several reports received from the same source. No further information is available.
Age: 1.81
Sex: F
Vaccine: MMR
Symptoms: Measles post vaccine
Clinical narrative: Information has been received from a registered nurse concerning a 22 month old female with a history of low gestational birth weight and no allergies who on 13-MAY-2009 was vaccinated with the first dose of MMR II (lot# 663101/1728X, rHA, 0.5ml, subcutaneous injection). There was no concomitant medication and no lab diagnostics studies performed. On 26-MAY-2009 the patient was diagnosed with measles. The patient visited the office for some medication. No treatment was required and the patient was recovering at the time of reporting. This is one of several cases from the same source. Additional information has been requested.
Age: 6.0
Sex: M
Vaccine: DTAP, HEP, MMR, VARCEL
Symptoms: Gait disturbance, Inappropriate schedule of drug administration, Rash, Vaccination error
Clinical narrative: Information has been received from a consumer concerning her now 9 year old son who at 6 year old (approximately in 2006) was vaccinated with a dose of MMR II (LOT# not reported). Concomitant therapy included: diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid booster, RECOMBIVAX HB, VARIVAX and other unspecified vaccines. The patient experienced a rash after he received the MMR II and on an unspecified date the patient woke up with had difficulty walking and the mother had to "carry the patient to the car". The patient was seen by physician and recovered on an unspecified date. No further information is available.
Sex: M
Vaccine: MMR
Symptoms: No therapeutic response, Rubella antibody negative
Clinical narrative: Information has been received from a nurse practitioner concerning a male patient who had received 2 doses of MMR II had negative titers for rubella. The patient received his first dose of MMR II as a child. In September 2008 his rubella titers were negative. He then received dose 2 of MMR II in January 2009. In April 2009 his rubella titers were still negative. The patient sought unspecified medical attention. Additional information has been requested.
Age: 1.3
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Information has been received from a medical assistant concerning a 16 month old female who on 28-APR-2009 was vaccinated subcutaneously with a 0.5mL dose of VARIVAX (Merck) (LOT# 662577/0047Y).  On an unspecified date after vaccination the patient experienced injection site redness and swelling.  It also reported that unspecified medical attention was sought and the patient was recovered.  A lot check has been initiated.  A standard lot check investigation was performed.  All in-process quality checks for the lot number in question were satisfactory.  The lot met the requirements of the Center for Biologics Evaluation and Research and was released.  (Complaint ID # 154673).  This is one of several reports received from the same source.  No further information is available.
Age: 29.0
Sex: U
Vaccine: MMR
Symptoms: No therapeutic response
Clinical narrative: Information has been received from a physician concerning a 29 year old patient who an unspecified date was vaccinated with a dose of MMR II (LOT# not reported). Recently, the patient came into the office and had blood work that showed no titers to any of the components of MMR II. No additional information was available at the time of this report. This is one of the reports from the same source. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: No therapeutic response
Clinical narrative: Information has been received from a physician concerning a patient who on an unspecified date "a long time ago" was vaccinated with a dose of MMR II (LOT# not reported). Recently, the patient came into the office and had blood work that showed no titers to two of the components of MMR II, but did have titers for one component. No additional information was available at the time of this report. This is one of the reports from the same source. Additional information has been requested.
Age: 1.48
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse concerning a 24 month old male who on 16-APR-2008 was vaccinated with a dose of VARIVAX (Merck) (Lot # 660409/1998U). On 31-AUG-2009, the patient developed a mild case of chickenpox with less than 50 lesions and no fever. The patient's outcome was not reported. The patient sought medical attention, was seen in the office. Follow up information has been received from a registered nurse concerning this patient. She stated that the patient also received a dose of MMR II (MSD) on 16-APR-2008. (Lot # not provided). Further follow up information has been received from a registered nurse concerning a patient with not known medical history who on 16-APR-2009 (previously reported as 16-APR-2008) received a dose of VARIVAX (Merck) (Lot # 660409/1998U) and also received on unspecified date (previously reported as 16-APR-2008) a dose of MMR II (MSD). The patient experienced a mild case of chicken pox. The patient was seen in emergency room (ER) on 02-SEP-2009 and released. No relevant diagnostic test was performed. At the time of this report, the patient recovered. Additional information has been requested.
Age: 37.0
Sex: F
Vaccine: MMR
Symptoms: Erythema, Headache, Myalgia, Pruritus, Pyrexia
Clinical narrative: Information has been received from a 37 year old female registered pharmacist with no medical history and drug allergies who on 30-SEP-2009 was vaccinated subcutaneously with one dose of MMR II (lot number not reported). On 07-OCT-2009 she was vaccinated with a dose of FLUARIX. There was no other concomitant therapy. On 09-OCT-2009 she experienced muscle pains, headache and fever that lasted for about 3 days. On 12-OCT-2009 she experienced itching over her body and red spots that lasted for 3 days and resolved on their own. The pharmacist mentioned that she saw her physician on 15-OCT-2009. No treatment was provided. The pharmacist stated that she had persistent left wrist pain where she could not lift anything heavy or drive due to the pain. She was currently working as a pharmacist but can only perform light duty. There was no laboratory diagnostics studies performed. At the time of the report, the patient had not recovered. Additional information has been requested.
Age: 26.0
Sex: F
Vaccine: MMR
Symptoms: Measles antibody negative, Mumps antibody test negative, No therapeutic response, Rubella antibody negative
Clinical narrative: Information has been received from a medical assistant concerning an approximately 26 year old female who in the early 1970s was vaccinated with the first dose of MMR II (lot number not reported). In 1990, the patient had her titers drawn and was shown to have no immunity to mumps. The patient received a second dose of MMR II (lot number not reported) in early 1992. In 2008, she had her titers drawn again and was shown to have no immunity to measles, mumps or rubella. In the late summer of 2008, the patient received a third dose of MMR II (lot number not reported) because of her lack of immunity. The patient had sought unspecified medical attention. Additional information has been requested.
Age: 3.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received firm a company representative concerning a 36 month old patient who in approximately 2008 was vaccinated with the first dose of VARIVAX (Merck). There were no any lab diagnostic studies performed. On approximately 10-SEP-2009 the patient experienced a breakthrough case of varicella. At the time of this report the patient's outcome was not recovered. The patient sought for unspecified medical attention. No further information is available.
Sex: F
Vaccine: MMR
Symptoms: Asthenia, Lymphadenitis, Nausea, Pain, Rash
Clinical narrative: Information has been received from a female consumer who 14 days ago, on 13-OCT-2009 was vaccinated with dose of MMR II. The reporter mentioned that on 23-OCT-2009 she developed "painful lumps under her ear lobe and on the back of her head" after getting the vaccination. The reporter also stated that she experienced nausea and weakness "for a couple of days" after she received the MMR II. It was mentioned that "last night" on 26-OCT-2009 she developed a rash on one of her cheeks, which "spread to her other cheek today" on 27-OCT-2009. It was unknown if the patient sought medical attention. No further information was available.